LENZ Therapeutics, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Solana Beach, CA
LENZ chart
What traders are saying about $LENZ
Latest postsLENZ Therapeutics, Inc. news
- LENZ Therapeutics (LENZ) Stock Fair Value Moves Lower As Analysts Split On VIZZ
Yahoo Finance ·
- LENZ (LENZ) Q3 2026 Earnings Call Transcript
fool.com ·
- LENZ Therapeutics (LENZ) Stock Rallies As Q3 Results Expose Cash Burn
Yahoo Finance ·
- LENZ Therapeutics Q3 Earnings Call Highlights
marketbeat.com ·
- LENZ Therapeutics, Inc. (LENZ) Reports Q3 Loss, Misses Revenue Estimates
Yahoo Finance ·
- LENZ Therapeutics Reports Third Quarter 2026 Financial Results, Announces Strategic Consumer Marketing Focused Reorganization and CEO Succession
Yahoo Finance ·
- Regeneron (REGN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Yahoo Finance ·
- LENZ Therapeutics to Report Third Quarter 2026 Financial Results on October 29, 2026
Yahoo Finance ·
- LENZ Therapeutics (LENZ) Stock Fair Value Falls After Analysts Cut VIZZ Launch Expectations
Yahoo Finance ·
- LENZ Therapeutics (LENZ) Stock Sees Fair Value Moves Lower After Analyst Target Cuts
Yahoo Finance ·
- LENZ Therapeutics Inc (LENZ) (Q2 2026) Earnings Call Highlights: VIZZ Launch Momentum ...
Yahoo Finance ·
- LENZ Therapeutics, Inc. Q2 2026 Earnings Call Summary
app.moby.co ·
LENZ Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $19.1M | $0 | – | – |
| Net income | -$82.1M | -$49.8M | -$70.0M | -$101.1M |
| Diluted EPS | $-2.85 | $-2.34 | $-35.71 | $-1.84 |
| Total assets (year end) | $305.9M | $215.3M | $70.4M | $321.9M |
| Cash and equivalents (year end) | $25.2M | $20.2M | $35.1M | $47.7M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About LENZ Therapeutics, Inc.
- Ticker
- LENZ (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Solana Beach, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1815776
- Former names
- Graphite Bio, Inc.
Frequently asked questions
What exchange is LENZ Therapeutics, Inc. listed on?
LENZ Therapeutics, Inc. trades on the Nasdaq under the ticker symbol LENZ.
What industry is LENZ Therapeutics, Inc. in?
LENZ Therapeutics, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is LENZ Therapeutics, Inc. headquartered?
LENZ Therapeutics, Inc.'s business address on file with the SEC is in Solana Beach, CA.
When does LENZ Therapeutics, Inc.'s fiscal year end?
LENZ Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did LENZ Therapeutics, Inc. report?
LENZ Therapeutics, Inc. reported $19.1M in revenue for calendar year 2025, according to its SEC filings.